Navigation Links
FDA Approves Electronic Common Technical Document (eCTD) for Laureate's Regulatory Submissions
Date:9/8/2011

PRINCETON, N.J., Sept. 8, 2011 /PRNewswire/ -- Laureate Biopharmaceutical Services, Inc. announced today that their Regulatory Services Group (RSG) has been approved by the Food and Drug Administration (FDA) to submit electronic common technical document (eCTD) regulatory submissions to the Agency. The 4 gigabyte test submission comprising CMC, preclinical and clinical data was reviewed, validated and approved without errors and in record time. The endorsement complements Laureate's recent approval to use FDA's electronic submission gateway (ESG).

"This is a major milestone towards completing Laureate's strategy of offering clients submission-ready chemistry, manufacturing and control (CMC) reports, as well as providing a complete regulatory submission service," commented Robert Burford Ph.D. Vice President Regulatory Services. "Clients will now be able to have their regulatory submission services provided by Laureate independent of having clinical supplies manufactured by us."

Laureate's CEO, Michael A. Griffith, commented, "Approval to submit eCTDs to the FDA along with the recently announced approval to use FDA's electronic submission gateway offers Laureate customers a combined service, unique to the industry."  He continued, "By providing clients with a bulk drug substance (BDS) and/or drug product along with submission-ready CMC documentation and the capability to manage the actual submission process is part of Laureate's philosophy of providing clients with a superior contract manufacturing experience."

About Laureate Regulatory Services Group (RSG)

Laureate Regulatory Services Group publishes, submits and manages electronic IND, NDA and BLA submissions as a client service. Specializing in CMC documentation from Upstream, Downstream and Analytical functions performed for clients requiring BDS these reports are created in eCTD format.  Besides publishing and submission services, the RSG also offers a wid
'/>"/>

SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
2. FDA Approves Dendreons Los Angeles Cancer Immunotherapy Manufacturing Facility
3. FDA Approves New Device to Treat Brain Aneurysms
4. European Commission Approves DuPont Tender Offer to Acquire Danisco
5. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
6. European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
7. FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy
8. European Union Approves Maize with Herculex® I/Herculex® RW and Herculex® RW/ Herculex® I/Roundup Ready® Corn 2 Trait Stacks for Import, Food, Feed & Processing
9. FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
10. Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
11. FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 01, 2015 Spirax Sarco, the leader ... proud to announce that for the first time in ... winner of a Queen’s Award for Innovation – the ... and manufacture of a unique flowmeter. , The Spirax ... to traditional steam flow measurement. The device provides ...
(Date:4/30/2015)... 2015 Nitto Avecia, a leading ... increased capacity and production capability to serve biotechnology ... and service fulfillment continues to drive Nitto Avecia ... throughput capacities. , In Fall 2014, ... process equipment at its Milford, MA facility, which ...
(Date:4/30/2015)... , April 30, 2015  Pfenex Inc. ... in the development of biosimilar therapeutics including high ... the closing of its previously announced underwritten public ... at a public offering price of $15.50 per ... the underwriters of their option to purchase up ...
(Date:4/30/2015)... April 30, 2015 Available in ... http://www.lespausa.com , Phytomer’s DOUCEUR INTEMPORELLE Restorative ... reactive skin while battling the weakening threat of ... cream is formulated with star ingredient GLYCOSEA, a ... in a complex of soothing minerals and trace ...
Breaking Biology Technology:Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3
... 2012  Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Goldman Sachs Global Healthcare Conference 2012 on ... the Terranea Resort in Rancho Palos Verdes, California.  The ...
... 2012 TOKU-E Company ( http://www.toku-e.com ) ... faster dissolving dust-free grade (DF) Sodium Dodecyl Sulfate (SDS). ... dust particles is known to cause eye and skin ... chronic skin hypersensitivity, with some people being affected more ...
... SEATTLE, May 29, 2012 Cell Therapeutics, Inc. ("CTI") (Nasdaq ... an agreement to sell, subject to customary closing conditions, $40 ... and warrants to purchase shares of its common stock (and ... upon conversion of the Series 15 Convertible Preferred Stock and ...
Cached Biology Technology:Watson to Present at Goldman Sachs Global Healthcare Conference 2012 2TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications 2Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 2Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 3Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 4Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 5Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 6
(Date:3/20/2015)... , Mar. 20, 2015 Research and ... the addition of the "India Sensors Market ... offering. The sensor market is projected ... 2020 Consumer electronics, automotive, industrial and ... sensors in the country. In addition, adoption of ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/19/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet ... on Washington DC,s Fox 5 News ... Next Great Thing", host Laura Evans calls the ... really big breakthrough in mobile payment.,  Award-winning ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... fictitious storybook character Dr. Doolittle was known for ... professor of psychology at Rochester Institute of Technology, ... object discrimination in goldfish and echolocation in dolphins ... of animal perception and cognition. DeLong,s theories ...
... California, Davis, and BGI, the world,s largest genomic institute, ... will change the landscape of genomic sciences in California ... the areas of food security and human, animal and ... BGI sequencing facility for immediate use on the UC ...
... CAMDEN -- In this era of environmental consciousness, many ... is taking the term quite literally. Elizabeth Demaray, an ... sides of New York City skyscrapers to counteract the lack ... Skyscrapers Project" was featured as part of New York,s Art ...
Cached Biology News:Go fish! RIT psychology professor trains goldfish for object perception research 2UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento 2UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento 3Rutgers professor uses lichen to help cities go green 2Rutgers professor uses lichen to help cities go green 3
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... TYPE II Reacts with most of ... cell keratin of 86 and 58kD and ... keratin reactivity is found on human epidermal ... Immunogen: Human epidermal cells ...
BD BioCoat Fibronectin 150 mm Culture Dishes...
... CLS number is a new product number, ... If showing no availability yet, please order ... contact customer service for assistance. ... Dim: surface area 500 cm 2 ...
Biology Products: